drugs
-
Health Care
Heartland Speaker Warns Millennials to Take Healthcare and Health Insurance Seriously
by Nancy Thorner June 19, 2017Charlie Katebi – a fellow in health care reform at the Millennial Policy Center at the Liberty Group in Denver – spoke on the topic of “A Health Care Agenda for Millennials.”
-
Uncategorized
Maryland’s Drug Price Gouging Law: The Potential Consequences
by Thomas Hemphill June 12, 2017On May 26, Maryland became the first state to pass a law which applies specifically to “price gouging” practices by generic pharmaceutical manufacturers of essential drugs.
-
The reported success of the Affordable Care Act (ACA or ObamaCare) is based on enrollment numbers. Millions more have “coverage.”
-
Professor and student at the Harvard T.H. Chan School of Public Health recently argued Republicans in Congress are trying to send health care to hell in a handbasket by repealing and replacing the Affordable Care Act.
-
Health Care
Basic Economic Thinking Would Fix the Broken US Health Care System
by David S. D'Amato November 11, 2016Obamacare is seemingly grinding to a half as a result of being fundamentally at odds with basic economic principles
-
Health Care
EpiPens Become a Life-saving Object of Greed
by Nancy Thorner and Ed Ingold September 7, 2016EpiPens are a decades-old way of delivering epinephrine, a hormone that counters the potentially fatal effects of severe allergic reactions to things such as bee stings and peanuts. To children subject to such allergic reaction, having an EpiPen available can be a matter of life and death.
-
Budgets/TaxesFeatured
States Should Not Increase Tobacco Use Age to 21
by Lindsey Stroud May 2, 2016Some states, including California and Illinois, are now considering proposals that would increase the legal age limit required to consume tobacco and tobacco-like products, including electronic cigarettes, from 18 years old to 21. Hawaii was the first state to enact such laws, which became effective January 1, 2016.
-
The Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2015 (RESULT Act) would fast-track drug and medical device applications through the Food and Drug Administration’s sluggish and costly approval process. The act would streamline new products already vetted by a government agency in another Organization for Economic Cooperation and Development nation with a proven record of providing safe medical devices and pharmaceutical products.